Invitae, a leading medical genetics company, announced the availability of Detect Hereditary Pancreatic Cancer, a testing programme that offers no-charge genetic testing and counselling to patients ...

– Collaboration will simplify providers' and patients' access to discrete test results that can inform more precise, personalized medicine – SAN FRANCISCO, March 21, 2023 /PRNewswire/ -- Invitae (NVTA ...

A new survey released today shows 73 percent of Americans are aware of genetic testing for hereditary cancers – a significant increase over just a few years ago. Previous research found that in 2010 ...

SYDNEY, AUSTRALIA / ACCESSWIRE / March 13, 2018 / Medical clinic and research facility Olympus Genetics Pty Ltd, based in Sydney Olympic Park, NSW, Australia, are pleased to announce the provision of ...